Hennion & Walsh Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $769K | Sell |
224,927
-62,888
| -22% | -$209K | 0.02% | 638 |
|
|
2026
Q1 | $1.03M | Sell |
287,815
-21,432
| -7% | -$85.2K | 0.03% | 503 |
|
|
2025
Q4 | $1.09M | Buy |
309,247
+3,809
| +1% | +$13K | 0.04% | 495 |
|
|
2025
Q3 | $996K | Buy |
305,438
+31,179
| +11% | +$98.2K | 0.04% | 510 |
|
|
2025
Q2 | $672K | Buy |
274,259
+24,733
| +10% | +$125K | 0.03% | 589 |
|
|
2025
Q1 | $1.66M | Buy |
249,526
+12,027
| +5% | +$119K | 0.07% | 324 |
|
|
2024
Q4 | $2.99M | Buy |
237,499
+16,453
| +7% | +$248K | 0.14% | 190 |
|
|
2024
Q3 | $4.08M | Buy |
221,046
+16,936
| +8% | +$347K | 0.19% | 129 |
|
|
2024
Q2 | $4.39M | Sell |
204,110
-27,177
| -12% | -$624K | 0.23% | 98 |
|
|
2024
Q1 | $6.23M | Buy |
231,287
+37,937
| +20% | +$1.08M | 0.33% | 52 |
|
|
2023
Q4 | $5.79M | Buy |
193,350
+42,276
| +28% | +$933K | 0.33% | 60 |
|
|
2023
Q3 | $3.1M | Buy |
151,074
+25,845
| +21% | +$470K | 0.2% | 126 |
|
|
2023
Q2 | $2.49M | Buy |
125,229
+21,597
| +21% | +$436K | 0.15% | 184 |
|
|
2023
Q1 | $1.77M | Buy |
103,632
+4,641
| +5% | +$90.9K | 0.11% | 230 |
|
|
2022
Q4 | $1.94M | Buy |
98,991
+40,919
| +70% | +$754K | 0.12% | 215 |
|
|
2022
Q3 | $927K | Buy |
58,072
+14,460
| +33% | +$226K | 0.06% | 344 |
|
|
2022
Q2 | $600K | Buy |
+43,612
| New | +$520K | 0.04% | 449 |
|
